Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice
- PMID: 7880197
- DOI: 10.1002/art.1780380321
Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice
Abstract
Objective: To elucidate the role played by HLA-B51 in the neutrophil hyperfunction of Behçet's disease, we determined the superoxide production by purified peripheral blood neutrophils from Behçet's disease patients, from HLA-B51 positive healthy individuals, and from HLA-B51 transgenic mice.
Methods: Neutrophil function was evaluated by flow cytometric analysis, detecting the conversion of 2',7'-dichlorofluorescin diacetate into dichloroflurescein, induced by superoxide in the neutrophils.
Results: A significant correlation between the neutrophil hyperfunction and the possession of HLA-B51 phenotype, regardless of the presence of the disease, was observed in humans. FMLP-stimulated neutrophils (without in vitro priming) from HLA-B51 transgenic mice, but not those from HLA-B35 transgenic mice or from nontransgenic mice, produced substantial amounts of superoxide.
Conclusion: The HLA-B51 molecule itself may be responsible, at least in part, for neutrophil hyperfunction in Behçet's disease.
Similar articles
-
[Research for basic and clinical aspects of Behcet's disease--recent advance and future--].Nihon Rinsho. 1996 Mar;54(3):870-84. Nihon Rinsho. 1996. PMID: 8904250 Review. Japanese.
-
New perspective on Behçet's disease.Int Rev Immunol. 1997;14(1):89-96. doi: 10.3109/08830189709116847. Int Rev Immunol. 1997. PMID: 9203029 Review.
-
Hyperreactivity of neutrophils and abnormal T cell homeostasis: a new insight for pathogenesis of Behçet's disease.Int Rev Immunol. 1997;14(1):11-9. doi: 10.3109/08830189709116841. Int Rev Immunol. 1997. PMID: 9203023 Review.
-
Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101.Am J Ophthalmol. 1993 Oct 15;116(4):406-9. doi: 10.1016/s0002-9394(14)71396-0. Am J Ophthalmol. 1993. PMID: 8213969
-
HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome.Am J Med. 1987 Oct;83(4):666-72. doi: 10.1016/0002-9343(87)90896-5. Am J Med. 1987. PMID: 3314492
Cited by
-
Behçet's disease.Postgrad Med J. 2000 Oct;76(900):629-37. doi: 10.1136/pmj.76.900.629. Postgrad Med J. 2000. PMID: 11009577 Free PMC article. Review.
-
Panuveitis simulating ocular Behçet's in cases of chronic myelogenous leukaemia in remission.BMJ Case Rep. 2017 Nov 23;2017:bcr2017222238. doi: 10.1136/bcr-2017-222238. BMJ Case Rep. 2017. PMID: 29170182 Free PMC article.
-
Understanding Behçet's Disease in the Context of Innate Immunity Activation.Front Immunol. 2020 Oct 20;11:586558. doi: 10.3389/fimmu.2020.586558. eCollection 2020. Front Immunol. 2020. PMID: 33193413 Free PMC article. Review.
-
Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.Clin Exp Immunol. 2014 Feb;175(2):150-66. doi: 10.1111/cei.12223. Clin Exp Immunol. 2014. PMID: 24128276 Free PMC article. Review.
-
The proportion of C1q-high and ISG15-high monocytes in the skin of patients with Behçet disease.Front Pharmacol. 2023 Mar 7;14:1110741. doi: 10.3389/fphar.2023.1110741. eCollection 2023. Front Pharmacol. 2023. PMID: 36959847 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials